Status:
NOT_YET_RECRUITING
Patient Education Strategy for Breast Cancer Patients During Perioperative Hospitalization Stage
Lead Sponsor:
Fudan University
Conditions:
Breast Carcinoma
Patient Education
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Introduction Breast cancer remains a leading global health concern, with significant psychological challenges during the perioperative period. Traditional patient education focuses on disease manageme...
Eligibility Criteria
Inclusion
- More than 18 years old
- Female
- Patient with early-stage breast cancer with preoperative pathology confirming invasive breast carcinoma or ductal carcinoma in situ
- No clinical or imaging evidence of distant metastasis
- Patients to receive breast surgery during hospitalizaiton (including mastectomy, breast conserving therapy, reconstrucion, etc.)
- Be able and willing to sign the Informed Consent Form (ICF)
Exclusion
- Patients with locally advanced breast cancer to receive neoadjuvant therapy
- Patients currently participating in other clinical trials, which may have impact on the participation in this trial
- Previous history of breast cancer (patients with ipsilateral recurrence after breast sparing surgery)
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2026
Estimated Enrollment :
1138 Patients enrolled
Trial Details
Trial ID
NCT06965556
Start Date
June 1 2025
End Date
October 31 2026
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, China, 200032